{"id":238082,"date":"2026-09-09T13:56:14","date_gmt":"2026-09-09T08:26:14","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=238082"},"modified":"2026-09-09T13:56:14","modified_gmt":"2026-09-09T08:26:14","slug":"biofil-chemicals-and-pharmaceuticals-share-price-buy-hold-or-sell","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/biofil-chemicals-and-pharmaceuticals-share-price-buy-hold-or-sell\/","title":{"rendered":"Biofil Chemicals & Pharmaceuticals: Should You Buy, Hold, or Sell Right Now?"},"content":{"rendered":"

Biofil Chemicals & Pharmaceuticals share price Rs 31.50 (NSE), well off its 52-week high. 52-week range Rs 25.22 to Rs 46.82. Very rich valuation on thin, stagnant earnings.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Biofil Chemicals & Pharmaceuticals Ltd share price is trading around Rs 31.5, more than 32 percent below its 52-week high of Rs 46.82 but above its 52-week low of Rs 25.22. The company reported full-year revenue of approximately Rs 34.3 crore with a thin profit of Rs 0.48 crore, and has delivered poor sales growth of just -4.5 percent over the past five years, with a low return on equity of just 1.24 percent averaged over three years. The stock trades at a rich 106.67 times earnings against the pharmaceutical sector average near 51.2 times, a valuation that appears disconnected from the company’s stagnant underlying growth history, warranting particular caution.<\/p>\n<\/p><\/div>\n

Biofil Chemicals & Pharmaceuticals share price has fallen more than 32 percent from its 52-week high of Rs 46.82, with Biofil Chemicals & Pharmaceuticals share price now trading near Rs 31.5 on the NSE, above its 52-week low of Rs 25.22. Given a very rich valuation set against a stagnant sales growth history, this article presents the numbers plainly before laying out a careful, cautious view.<\/p>\n

This Biofil Chemicals & Pharmaceuticals overview walks through the company’s thin trailing profitability, the mismatch between its valuation and growth history, shareholding pattern and the technical setup, using figures sourced from public filings.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n